Novel motif:135: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:16, 9 September 2013
name: | motif135_TNKYTGCAKA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032502 | developmental process | 1.309102e-15 |
GO:0007275 | multicellular organismal development | 2.002286e-15 |
GO:0032989 | cellular component morphogenesis | 2.140207e-15 |
GO:0050896 | response to stimulus | 9.715980e-15 |
GO:0014866 | skeletal myofibril assembly | 9.793700e-15 |
GO:0031032 | actomyosin structure organization | 7.018285e-14 |
GO:0032501 | multicellular organismal process | 2.495409e-13 |
GO:0031175 | neuron projection development | 2.582720e-13 |
GO:0048856 | anatomical structure development | 2.749784e-13 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 3.107611e-13 |
GO:0048731 | system development | 5.697593e-13 |
GO:0000904 | cell morphogenesis involved in differentiation | 6.608388e-13 |
GO:0009653 | anatomical structure morphogenesis | 1.082995e-12 |
GO:0048468 | cell development | 1.538010e-12 |
GO:0000902 | cell morphogenesis | 4.032875e-12 |
GO:0048739 | cardiac muscle fiber development | 8.547802e-12 |
GO:0048812 | neuron projection morphogenesis | 1.011989e-11 |
GO:0065007 | biological regulation | 1.294517e-11 |
GO:0030239 | myofibril assembly | 2.133598e-11 |
GO:0060415 | muscle tissue morphogenesis | 4.127744e-11 |
GO:0006941 | striated muscle contraction | 4.735976e-11 |
GO:0030030 | cell projection organization | 5.046330e-11 |
GO:0007409 | axonogenesis | 8.776198e-11 |
GO:0050789 | regulation of biological process | 1.115918e-10 |
GO:0002682 | regulation of immune system process | 1.239431e-10 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1.691610e-10 |
GO:0048858 | cell projection morphogenesis | 1.777643e-10 |
GO:0030240 | skeletal muscle thin filament assembly | 1.979745e-10 |
GO:0032990 | cell part morphogenesis | 2.289078e-10 |
GO:0030154 | cell differentiation | 6.185280e-10 |
GO:0048644 | muscle organ morphogenesis | 6.479863e-10 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 7.072639e-10 |
GO:0055003 | cardiac myofibril assembly | 8.345408e-10 |
GO:0048747 | muscle fiber development | 9.028483e-10 |
GO:0055002 | striated muscle cell development | 1.124108e-9 |
GO:0007010 | cytoskeleton organization | 1.240178e-9 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.351125e-9 |
GO:0060537 | muscle tissue development | 1.584468e-9 |
GO:0006955 | immune response | 1.742640e-9 |
GO:0022008 | neurogenesis | 1.961622e-9 |
GO:0042692 | muscle cell differentiation | 2.050365e-9 |
GO:0048666 | neuron development | 2.272860e-9 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.348153e-9 |
GO:0030182 | neuron differentiation | 2.610840e-9 |
GO:0055001 | muscle cell development | 2.816677e-9 |
GO:0048869 | cellular developmental process | 3.485872e-9 |
GO:0071636 | positive regulation of transforming growth factor beta production | 3.861924e-9 |
GO:0051877 | pigment granule aggregation in cell center | 4.130212e-9 |
GO:0006068 | ethanol catabolic process | 4.170872e-9 |
GO:0048699 | generation of neurons | 4.505154e-9 |
GO:0009887 | organ morphogenesis | 4.596841e-9 |
GO:0045494 | photoreceptor cell maintenance | 5.064689e-9 |
GO:0030048 | actin filament-based movement | 5.163647e-9 |
GO:0009308 | amine metabolic process | 6.819241e-9 |
GO:0044106 | cellular amine metabolic process | 7.476968e-9 |
GO:0043954 | cellular component maintenance | 8.320361e-9 |
GO:0042060 | wound healing | 9.279794e-9 |
GO:0006911 | phagocytosis, engulfment | 9.286647e-9 |
GO:0007596 | blood coagulation | 9.332371e-9 |
GO:0060632 | regulation of microtubule-based movement | 9.589686e-9 |
GO:0007599 | hemostasis | 1.079427e-8 |
GO:0070831 | basement membrane assembly | 1.608342e-8 |
GO:0055013 | cardiac muscle cell development | 1.721229e-8 |
GO:0007399 | nervous system development | 2.073455e-8 |
GO:0051146 | striated muscle cell differentiation | 2.095174e-8 |
GO:0006069 | ethanol oxidation | 2.439002e-8 |
GO:0048769 | sarcomerogenesis | 2.537779e-8 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 2.769903e-8 |
GO:0050794 | regulation of cellular process | 3.052262e-8 |
GO:0002576 | platelet degranulation | 3.356205e-8 |
GO:0010759 | positive regulation of macrophage chemotaxis | 4.209921e-8 |
GO:0070252 | actin-mediated cell contraction | 4.355425e-8 |
GO:0003007 | heart morphogenesis | 4.673241e-8 |
GO:0030049 | muscle filament sliding | 4.745907e-8 |
GO:0045214 | sarcomere organization | 4.746694e-8 |
GO:0060027 | convergent extension involved in gastrulation | 5.914756e-8 |
GO:0010758 | regulation of macrophage chemotaxis | 6.585754e-8 |
GO:0009611 | response to wounding | 6.708429e-8 |
GO:0031099 | regeneration | 8.094811e-8 |
GO:0006520 | cellular amino acid metabolic process | 8.896642e-8 |
GO:0030036 | actin cytoskeleton organization | 1.009595e-7 |
GO:0042982 | amyloid precursor protein metabolic process | 1.011853e-7 |
GO:0030029 | actin filament-based process | 1.021142e-7 |
GO:0071622 | regulation of granulocyte chemotaxis | 1.037326e-7 |
GO:0021987 | cerebral cortex development | 1.260618e-7 |
GO:0031102 | neuron projection regeneration | 1.294611e-7 |
GO:0045579 | positive regulation of B cell differentiation | 1.309027e-7 |
GO:0001771 | immunological synapse formation | 1.329330e-7 |
GO:0071675 | regulation of mononuclear cell migration | 1.396852e-7 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 1.695384e-7 |
GO:0006928 | cellular component movement | 1.804259e-7 |
GO:0008628 | induction of apoptosis by hormones | 1.951908e-7 |
GO:0071634 | regulation of transforming growth factor beta production | 1.990542e-7 |
GO:0007507 | heart development | 1.999094e-7 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.016151e-7 |
GO:0005981 | regulation of glycogen catabolic process | 2.106725e-7 |
GO:0000185 | activation of MAPKKK activity | 2.106725e-7 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 2.224853e-7 |
GO:0050878 | regulation of body fluid levels | 2.284587e-7 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 2.611071e-7 |
GO:0006936 | muscle contraction | 2.673490e-7 |
GO:0006208 | pyrimidine base catabolic process | 3.411430e-7 |
GO:0043297 | apical junction assembly | 3.973995e-7 |
GO:0042221 | response to chemical stimulus | 4.281299e-7 |
GO:0040011 | locomotion | 4.490250e-7 |
GO:0006935 | chemotaxis | 4.767849e-7 |
GO:2000052 | positive regulation of non-canonical Wnt receptor signaling pathway | 4.815199e-7 |
GO:0048729 | tissue morphogenesis | 5.094243e-7 |
GO:0048738 | cardiac muscle tissue development | 6.083920e-7 |
GO:0007015 | actin filament organization | 6.176844e-7 |
GO:0071840 | cellular component organization or biogenesis | 7.784618e-7 |
GO:0070098 | chemokine-mediated signaling pathway | 7.790864e-7 |
GO:0050690 | regulation of defense response to virus by virus | 8.013679e-7 |
GO:0030335 | positive regulation of cell migration | 8.730744e-7 |
GO:0019752 | carboxylic acid metabolic process | 8.907484e-7 |
GO:0007154 | cell communication | 8.948397e-7 |
GO:0046113 | nucleobase catabolic process | 9.208855e-7 |
GO:2000145 | regulation of cell motility | 9.351200e-7 |
GO:0032908 | regulation of transforming growth factor beta1 production | 9.994914e-7 |
GO:0006732 | coenzyme metabolic process | 1.023415e-6 |
GO:0007076 | mitotic chromosome condensation | 1.053510e-6 |
GO:0002067 | glandular epithelial cell differentiation | 1.055395e-6 |
GO:2000147 | positive regulation of cell motility | 1.245583e-6 |
GO:0055007 | cardiac muscle cell differentiation | 1.248254e-6 |
GO:0042180 | cellular ketone metabolic process | 1.281006e-6 |
GO:0006082 | organic acid metabolic process | 1.305466e-6 |
GO:0002831 | regulation of response to biotic stimulus | 1.460142e-6 |
GO:0035058 | nonmotile primary cilium assembly | 1.541209e-6 |
GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 1.624157e-6 |
GO:0030198 | extracellular matrix organization | 1.791090e-6 |
GO:0070830 | tight junction assembly | 1.841335e-6 |
GO:0014706 | striated muscle tissue development | 1.962091e-6 |
GO:0001890 | placenta development | 2.250164e-6 |
GO:0060263 | regulation of respiratory burst | 2.290280e-6 |
GO:0030431 | sleep | 2.332090e-6 |
GO:0040017 | positive regulation of locomotion | 2.373077e-6 |
GO:0023052 | signaling | 2.429368e-6 |
GO:0008037 | cell recognition | 2.483986e-6 |
GO:0071842 | cellular component organization at cellular level | 2.531061e-6 |
GO:0006749 | glutathione metabolic process | 2.646140e-6 |
GO:0007616 | long-term memory | 2.820277e-6 |
GO:0006790 | sulfur compound metabolic process | 2.895508e-6 |
GO:0001893 | maternal placenta development | 2.920541e-6 |
GO:0007499 | ectoderm and mesoderm interaction | 2.958442e-6 |
GO:2000096 | positive regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 2.969502e-6 |
GO:0032886 | regulation of microtubule-based process | 2.974471e-6 |
GO:0072358 | cardiovascular system development | 3.009559e-6 |
GO:0016043 | cellular component organization | 3.213177e-6 |
GO:0006575 | cellular modified amino acid metabolic process | 3.255871e-6 |
GO:0007059 | chromosome segregation | 3.310222e-6 |
GO:0051270 | regulation of cellular component movement | 3.361280e-6 |
GO:0042178 | xenobiotic catabolic process | 3.409173e-6 |
GO:0007165 | signal transduction | 3.437224e-6 |
GO:0045112 | integrin biosynthetic process | 3.493203e-6 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 3.514824e-6 |
GO:0030168 | platelet activation | 3.521692e-6 |
GO:0009605 | response to external stimulus | 3.589463e-6 |
GO:0007043 | cell-cell junction assembly | 3.648392e-6 |
GO:0007411 | axon guidance | 3.649826e-6 |
GO:2000831 | regulation of steroid hormone secretion | 3.826236e-6 |
GO:0030252 | growth hormone secretion | 3.868909e-6 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 3.909714e-6 |
GO:0034329 | cell junction assembly | 4.276423e-6 |
GO:0009888 | tissue development | 4.280853e-6 |
GO:0051272 | positive regulation of cellular component movement | 4.367462e-6 |
GO:0040012 | regulation of locomotion | 4.585117e-6 |
GO:2000050 | regulation of non-canonical Wnt receptor signaling pathway | 4.872964e-6 |
GO:0030540 | female genitalia development | 5.109487e-6 |
GO:0002688 | regulation of leukocyte chemotaxis | 5.130802e-6 |
GO:0007416 | synapse assembly | 5.137784e-6 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 5.349414e-6 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 5.598500e-6 |
GO:0050902 | leukocyte adhesive activation | 5.598500e-6 |
GO:2000833 | positive regulation of steroid hormone secretion | 5.662380e-6 |
GO:0045666 | positive regulation of neuron differentiation | 5.962727e-6 |
GO:0021756 | striatum development | 6.105273e-6 |
GO:0048513 | organ development | 6.145969e-6 |
GO:0010646 | regulation of cell communication | 6.316651e-6 |
GO:0034205 | beta-amyloid formation | 6.477988e-6 |
GO:0048251 | elastic fiber assembly | 6.955647e-6 |
GO:0030277 | maintenance of gastrointestinal epithelium | 6.955647e-6 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 7.567903e-6 |
GO:0008217 | regulation of blood pressure | 8.222849e-6 |
GO:0071392 | cellular response to estradiol stimulus | 8.275244e-6 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 8.632442e-6 |
GO:0043652 | engulfment of apoptotic cell | 8.632442e-6 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 8.632442e-6 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 8.632442e-6 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 8.632442e-6 |
GO:0016101 | diterpenoid metabolic process | 8.858505e-6 |
GO:0003012 | muscle system process | 9.195537e-6 |
GO:0007155 | cell adhesion | 9.212217e-6 |
GO:0002687 | positive regulation of leukocyte migration | 9.925507e-6 |
GO:0022607 | cellular component assembly | 1.023651e-5 |
GO:0050795 | regulation of behavior | 1.044214e-5 |
GO:0051094 | positive regulation of developmental process | 1.101319e-5 |
GO:0002683 | negative regulation of immune system process | 1.122501e-5 |
GO:0030878 | thyroid gland development | 1.161107e-5 |
GO:0061061 | muscle structure development | 1.171614e-5 |
GO:0002685 | regulation of leukocyte migration | 1.198940e-5 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1.217329e-5 |
GO:0043900 | regulation of multi-organism process | 1.273108e-5 |
GO:0085029 | extracellular matrix assembly | 1.274923e-5 |
GO:0000819 | sister chromatid segregation | 1.290445e-5 |
GO:0060022 | hard palate development | 1.330872e-5 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.368794e-5 |
GO:0021993 | initiation of neural tube closure | 1.442343e-5 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 1.487208e-5 |
GO:0006950 | response to stress | 1.497076e-5 |
GO:0032402 | melanosome transport | 1.499230e-5 |
GO:0061024 | membrane organization | 1.544221e-5 |
GO:0016044 | cellular membrane organization | 1.634474e-5 |
GO:0023051 | regulation of signaling | 1.668519e-5 |
GO:0010390 | histone monoubiquitination | 1.816442e-5 |
GO:0031103 | axon regeneration | 1.930293e-5 |
GO:0045597 | positive regulation of cell differentiation | 1.951890e-5 |
GO:0060259 | regulation of feeding behavior | 1.988999e-5 |
GO:0045216 | cell-cell junction organization | 2.036081e-5 |
GO:0006939 | smooth muscle contraction | 2.039664e-5 |
GO:0051918 | negative regulation of fibrinolysis | 2.059593e-5 |
GO:0006206 | pyrimidine base metabolic process | 2.157286e-5 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.192032e-5 |
GO:0006710 | androgen catabolic process | 2.244464e-5 |
GO:0002376 | immune system process | 2.311937e-5 |
GO:0003008 | system process | 2.322100e-5 |
GO:0065008 | regulation of biological quality | 2.479996e-5 |
GO:0060525 | prostate glandular acinus development | 2.513925e-5 |
GO:0000070 | mitotic sister chromatid segregation | 2.599885e-5 |
GO:2000836 | positive regulation of androgen secretion | 2.684262e-5 |
GO:2000500 | positive regulation of induction of apoptosis in response to chemical stimulus | 2.684262e-5 |
GO:0030261 | chromosome condensation | 2.696835e-5 |
GO:0051129 | negative regulation of cellular component organization | 2.714128e-5 |
GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development | 2.749193e-5 |
GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process | 2.855568e-5 |
GO:0034330 | cell junction organization | 2.881759e-5 |
GO:2000095 | regulation of Wnt receptor signaling pathway, planar cell polarity pathway | 3.022445e-5 |
GO:0010430 | fatty acid omega-oxidation | 3.090323e-5 |
GO:0090066 | regulation of anatomical structure size | 3.185446e-5 |
GO:0009988 | cell-cell recognition | 3.255904e-5 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 3.266488e-5 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 3.400330e-5 |
GO:0051893 | regulation of focal adhesion assembly | 3.467991e-5 |
GO:0051904 | pigment granule transport | 3.637812e-5 |
GO:0050920 | regulation of chemotaxis | 3.790110e-5 |
GO:0009296 | flagellum assembly | 3.793935e-5 |
GO:0010669 | epithelial structure maintenance | 3.803877e-5 |
GO:0030838 | positive regulation of actin filament polymerization | 3.860925e-5 |
GO:2000252 | negative regulation of feeding behavior | 3.961908e-5 |
GO:0008015 | blood circulation | 3.962044e-5 |
GO:0043064 | flagellum organization | 4.071571e-5 |
GO:0015788 | UDP-N-acetylglucosamine transport | 4.076526e-5 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 4.102114e-5 |
GO:0010977 | negative regulation of neuron projection development | 4.137309e-5 |
GO:0051917 | regulation of fibrinolysis | 4.137393e-5 |
GO:0061088 | regulation of sequestering of zinc ion | 4.195186e-5 |
GO:0061034 | olfactory bulb mitral cell layer development | 4.424341e-5 |
GO:0019859 | thymine metabolic process | 4.608342e-5 |
GO:0051895 | negative regulation of focal adhesion assembly | 4.617052e-5 |
GO:0001967 | suckling behavior | 4.694380e-5 |
GO:0050688 | regulation of defense response to virus | 4.694945e-5 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 4.850838e-5 |
GO:0060249 | anatomical structure homeostasis | 4.895586e-5 |
GO:0071844 | cellular component assembly at cellular level | 4.939286e-5 |
GO:0031347 | regulation of defense response | 4.947486e-5 |
GO:0048583 | regulation of response to stimulus | 5.347707e-5 |
GO:0050672 | negative regulation of lymphocyte proliferation | 5.406741e-5 |
GO:0007009 | plasma membrane organization | 5.489041e-5 |
GO:0030488 | tRNA methylation | 5.531185e-5 |
GO:0032851 | positive regulation of Rab GTPase activity | 5.565909e-5 |
GO:0051716 | cellular response to stimulus | 5.787357e-5 |
GO:0046320 | regulation of fatty acid oxidation | 5.857147e-5 |
GO:0048704 | embryonic skeletal system morphogenesis | 6.046467e-5 |
GO:0031114 | regulation of microtubule depolymerization | 6.276503e-5 |
GO:0006641 | triglyceride metabolic process | 6.375932e-5 |
GO:0044085 | cellular component biogenesis | 6.398813e-5 |
GO:0007517 | muscle organ development | 6.546723e-5 |
GO:0010955 | negative regulation of protein processing | 6.579054e-5 |
GO:0034605 | cellular response to heat | 6.656386e-5 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 6.676715e-5 |
GO:0030334 | regulation of cell migration | 6.814322e-5 |
GO:0042483 | negative regulation of odontogenesis | 6.862166e-5 |
GO:0048520 | positive regulation of behavior | 6.887506e-5 |
GO:0060513 | prostatic bud formation | 7.555258e-5 |
GO:0045786 | negative regulation of cell cycle | 7.627786e-5 |
GO:0032401 | establishment of melanosome localization | 7.639933e-5 |
GO:0031345 | negative regulation of cell projection organization | 7.651739e-5 |
GO:0048246 | macrophage chemotaxis | 7.739935e-5 |
GO:0060694 | regulation of cholesterol transporter activity | 7.791135e-5 |
GO:0010388 | cullin deneddylation | 7.876938e-5 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 8.006945e-5 |
GO:0050709 | negative regulation of protein secretion | 8.390662e-5 |
GO:0010035 | response to inorganic substance | 8.837029e-5 |
GO:0006721 | terpenoid metabolic process | 8.944997e-5 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 9.088775e-5 |
GO:0051656 | establishment of organelle localization | 9.132971e-5 |
GO:0006518 | peptide metabolic process | 9.178553e-5 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 9.341400e-5 |
GO:0070664 | negative regulation of leukocyte proliferation | 9.434696e-5 |
GO:0032369 | negative regulation of lipid transport | 9.502418e-5 |
GO:0051963 | regulation of synapse assembly | 9.596908e-5 |
GO:0042473 | outer ear morphogenesis | 9.791739e-5 |
GO:0050776 | regulation of immune response | 9.979105e-5 |
GO:0031129 | inductive cell-cell signaling | 9.987911e-5 |
GO:0006214 | thymidine catabolic process | 9.987911e-5 |
GO:0006097 | glyoxylate cycle | 9.987911e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1.017922e-4 |
GO:0035239 | tube morphogenesis | 1.051097e-4 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 1.052683e-4 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.054570e-4 |
GO:0032273 | positive regulation of protein polymerization | 1.098639e-4 |
GO:0043242 | negative regulation of protein complex disassembly | 1.111720e-4 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.112962e-4 |
GO:0002684 | positive regulation of immune system process | 1.121498e-4 |
GO:0009120 | deoxyribonucleoside metabolic process | 1.130879e-4 |
GO:0009408 | response to heat | 1.134055e-4 |
GO:0070482 | response to oxygen levels | 1.148421e-4 |
GO:0030595 | leukocyte chemotaxis | 1.171889e-4 |
GO:0043032 | positive regulation of macrophage activation | 1.198808e-4 |
GO:0009987 | cellular process | 1.208408e-4 |
GO:0042493 | response to drug | 1.233071e-4 |
GO:0071800 | podosome assembly | 1.236265e-4 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 1.242804e-4 |
GO:0032271 | regulation of protein polymerization | 1.245834e-4 |
GO:0030194 | positive regulation of blood coagulation | 1.269301e-4 |
GO:0050921 | positive regulation of chemotaxis | 1.285275e-4 |
GO:0032091 | negative regulation of protein binding | 1.305462e-4 |
GO:0001775 | cell activation | 1.309613e-4 |
GO:0035051 | cardiac cell differentiation | 1.326143e-4 |
GO:0006996 | organelle organization | 1.348971e-4 |
GO:0032891 | negative regulation of organic acid transport | 1.369670e-4 |
GO:0034754 | cellular hormone metabolic process | 1.387328e-4 |
GO:0050707 | regulation of cytokine secretion | 1.412055e-4 |
GO:0009060 | aerobic respiration | 1.462975e-4 |
GO:0002369 | T cell cytokine production | 1.537535e-4 |
GO:0002673 | regulation of acute inflammatory response | 1.565026e-4 |
GO:0071394 | cellular response to testosterone stimulus | 1.567856e-4 |
GO:0045908 | negative regulation of vasodilation | 1.567856e-4 |
GO:0048075 | positive regulation of eye pigmentation | 1.567856e-4 |
GO:0051338 | regulation of transferase activity | 1.569733e-4 |
GO:0006542 | glutamine biosynthetic process | 1.570072e-4 |
GO:0051905 | establishment of pigment granule localization | 1.589061e-4 |
GO:0033523 | histone H2B ubiquitination | 1.623946e-4 |
GO:0045906 | negative regulation of vasoconstriction | 1.626450e-4 |
GO:0051186 | cofactor metabolic process | 1.640313e-4 |
GO:0032026 | response to magnesium ion | 1.664382e-4 |
GO:0050710 | negative regulation of cytokine secretion | 1.665917e-4 |
GO:0032400 | melanosome localization | 1.673585e-4 |
GO:0030857 | negative regulation of epithelial cell differentiation | 1.736210e-4 |
GO:0006212 | uracil catabolic process | 1.737461e-4 |
GO:0006210 | thymine catabolic process | 1.737461e-4 |
GO:0045859 | regulation of protein kinase activity | 1.769396e-4 |
GO:0051960 | regulation of nervous system development | 1.808653e-4 |
GO:0030859 | polarized epithelial cell differentiation | 1.815071e-4 |
GO:0021544 | subpallium development | 1.848643e-4 |
GO:0048745 | smooth muscle tissue development | 1.891351e-4 |
GO:0045577 | regulation of B cell differentiation | 1.934588e-4 |
GO:0045088 | regulation of innate immune response | 1.961078e-4 |
GO:0015904 | tetracycline transport | 1.963307e-4 |
GO:0006091 | generation of precursor metabolites and energy | 2.073054e-4 |
GO:0043549 | regulation of kinase activity | 2.123063e-4 |
GO:0015980 | energy derivation by oxidation of organic compounds | 2.132068e-4 |
GO:0003013 | circulatory system process | 2.146360e-4 |
GO:0006637 | acyl-CoA metabolic process | 2.270394e-4 |
GO:0060197 | cloacal septation | 2.272455e-4 |
GO:0010757 | negative regulation of plasminogen activation | 2.320548e-4 |
GO:0050808 | synapse organization | 2.324603e-4 |
GO:0002577 | regulation of antigen processing and presentation | 2.387487e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.430402e-4 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 2.483563e-4 |
GO:0019217 | regulation of fatty acid metabolic process | 2.571293e-4 |
GO:0051179 | localization | 2.633860e-4 |
GO:0001523 | retinoid metabolic process | 2.690984e-4 |
GO:0033363 | secretory granule organization | 2.691102e-4 |
GO:0006907 | pinocytosis | 2.698274e-4 |
GO:0048807 | female genitalia morphogenesis | 2.711139e-4 |
GO:0031579 | membrane raft organization | 2.822474e-4 |
GO:0006639 | acylglycerol metabolic process | 2.851599e-4 |
GO:0002088 | lens development in camera-type eye | 2.898975e-4 |
GO:0060157 | urinary bladder development | 2.902455e-4 |
GO:0006434 | seryl-tRNA aminoacylation | 2.955449e-4 |
GO:0000066 | mitochondrial ornithine transport | 2.977323e-4 |
GO:0006099 | tricarboxylic acid cycle | 3.000927e-4 |
GO:0051234 | establishment of localization | 3.059716e-4 |
GO:0070544 | histone H3-K36 demethylation | 3.072239e-4 |
GO:0050820 | positive regulation of coagulation | 3.077665e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 3.080261e-4 |
GO:0051875 | pigment granule localization | 3.124320e-4 |
GO:0046356 | acetyl-CoA catabolic process | 3.235320e-4 |
GO:0050435 | beta-amyloid metabolic process | 3.250413e-4 |
GO:0006638 | neutral lipid metabolic process | 3.442730e-4 |
GO:0051650 | establishment of vesicle localization | 3.499188e-4 |
GO:0046476 | glycosylceramide biosynthetic process | 3.616847e-4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 3.616847e-4 |
GO:0006887 | exocytosis | 3.778810e-4 |
GO:0050803 | regulation of synapse structure and activity | 3.797641e-4 |
GO:0015887 | pantothenate transmembrane transport | 3.818855e-4 |
GO:0015878 | biotin transport | 3.818855e-4 |
GO:0006679 | glucosylceramide biosynthetic process | 3.853843e-4 |
GO:0051409 | response to nitrosative stress | 4.012749e-4 |
GO:0022037 | metencephalon development | 4.060048e-4 |
GO:0048584 | positive regulation of response to stimulus | 4.142605e-4 |
GO:0009108 | coenzyme biosynthetic process | 4.241244e-4 |
GO:0010755 | regulation of plasminogen activation | 4.277419e-4 |
GO:0031122 | cytoplasmic microtubule organization | 4.290357e-4 |
GO:0048073 | regulation of eye pigmentation | 4.345240e-4 |
GO:0070672 | response to interleukin-15 | 4.350219e-4 |
GO:0016574 | histone ubiquitination | 4.356875e-4 |
GO:0050807 | regulation of synapse organization | 4.406140e-4 |
GO:0009790 | embryo development | 4.555150e-4 |
GO:0060548 | negative regulation of cell death | 4.578842e-4 |
GO:0001666 | response to hypoxia | 4.588994e-4 |
GO:0001819 | positive regulation of cytokine production | 4.594392e-4 |
GO:0043623 | cellular protein complex assembly | 4.708580e-4 |
GO:0046121 | deoxyribonucleoside catabolic process | 4.766867e-4 |
GO:0001867 | complement activation, lectin pathway | 4.858169e-4 |
GO:0002832 | negative regulation of response to biotic stimulus | 4.921612e-4 |
GO:0033861 | negative regulation of NAD(P)H oxidase activity | 4.993923e-4 |
GO:0030327 | prenylated protein catabolic process | 4.993923e-4 |
GO:0009582 | detection of abiotic stimulus | 5.013583e-4 |
GO:0006805 | xenobiotic metabolic process | 5.015049e-4 |
GO:0060055 | angiogenesis involved in wound healing | 5.019789e-4 |
GO:0006145 | purine base catabolic process | 5.031192e-4 |
GO:0022603 | regulation of anatomical structure morphogenesis | 5.034239e-4 |
GO:0006952 | defense response | 5.146247e-4 |
GO:0001812 | positive regulation of type I hypersensitivity | 5.184405e-4 |
GO:0045617 | negative regulation of keratinocyte differentiation | 5.225738e-4 |
GO:0044281 | small molecule metabolic process | 5.243336e-4 |
GO:0043069 | negative regulation of programmed cell death | 5.264229e-4 |
GO:0009792 | embryo development ending in birth or egg hatching | 5.394541e-4 |
GO:0007613 | memory | 5.422655e-4 |
GO:0010763 | positive regulation of fibroblast migration | 5.562145e-4 |
GO:0009967 | positive regulation of signal transduction | 5.643260e-4 |
GO:0009966 | regulation of signal transduction | 5.712029e-4 |
GO:0016192 | vesicle-mediated transport | 5.814551e-4 |
GO:0001654 | eye development | 5.816880e-4 |
GO:0048562 | embryonic organ morphogenesis | 5.848984e-4 |
GO:0022414 | reproductive process | 5.907308e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 5.924318e-4 |
GO:0031100 | organ regeneration | 6.025839e-4 |
GO:0032094 | response to food | 6.057835e-4 |
GO:0002694 | regulation of leukocyte activation | 6.112272e-4 |
GO:0046104 | thymidine metabolic process | 6.196384e-4 |
GO:0042733 | embryonic digit morphogenesis | 6.289573e-4 |
GO:0045444 | fat cell differentiation | 6.314669e-4 |
GO:0009066 | aspartate family amino acid metabolic process | 6.323190e-4 |
GO:0060026 | convergent extension | 6.487430e-4 |
GO:0001763 | morphogenesis of a branching structure | 6.495787e-4 |
GO:0021678 | third ventricle development | 6.525717e-4 |
GO:0010647 | positive regulation of cell communication | 6.592630e-4 |
GO:0072079 | nephron tubule formation | 6.746881e-4 |
GO:0021858 | GABAergic neuron differentiation in basal ganglia | 6.768919e-4 |
GO:0048870 | cell motility | 6.794986e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 6.829865e-4 |
GO:0010464 | regulation of mesenchymal cell proliferation | 6.921105e-4 |
GO:0006766 | vitamin metabolic process | 6.923017e-4 |
GO:0071466 | cellular response to xenobiotic stimulus | 7.090839e-4 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 7.195810e-4 |
GO:0043066 | negative regulation of apoptosis | 7.206767e-4 |
GO:0045324 | late endosome to vacuole transport | 7.304075e-4 |
GO:0046947 | hydroxylysine biosynthetic process | 7.304075e-4 |
GO:0045234 | protein palmitoleylation | 7.304075e-4 |
GO:0006948 | induction by virus of host cell-cell fusion | 7.304075e-4 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 7.316503e-4 |
GO:0046716 | muscle cell homeostasis | 7.339912e-4 |
GO:0016477 | cell migration | 7.347182e-4 |
GO:0032571 | response to vitamin K | 7.376013e-4 |
GO:0006497 | protein lipidation | 7.388775e-4 |
GO:0021549 | cerebellum development | 7.396980e-4 |
GO:0030833 | regulation of actin filament polymerization | 7.496914e-4 |
GO:0009109 | coenzyme catabolic process | 7.539657e-4 |
GO:0030856 | regulation of epithelial cell differentiation | 7.551689e-4 |
GO:0000003 | reproduction | 7.627063e-4 |
GO:0033211 | adiponectin-mediated signaling pathway | 7.636626e-4 |
GO:0000096 | sulfur amino acid metabolic process | 7.723003e-4 |
GO:0023056 | positive regulation of signaling | 7.745064e-4 |
GO:0051303 | establishment of chromosome localization | 7.785122e-4 |
GO:0016358 | dendrite development | 7.841086e-4 |
GO:0034097 | response to cytokine stimulus | 7.912388e-4 |
GO:0060326 | cell chemotaxis | 7.928882e-4 |
GO:0000271 | polysaccharide biosynthetic process | 8.036125e-4 |
GO:0045818 | negative regulation of glycogen catabolic process | 8.077073e-4 |
GO:0072006 | nephron development | 8.117208e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 8.181518e-4 |
GO:0043403 | skeletal muscle tissue regeneration | 8.181518e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 8.204408e-4 |
GO:0001894 | tissue homeostasis | 8.228152e-4 |
GO:0045143 | homologous chromosome segregation | 8.309402e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 8.438290e-4 |
GO:0070613 | regulation of protein processing | 8.616051e-4 |
GO:0045766 | positive regulation of angiogenesis | 8.685460e-4 |
GO:0043010 | camera-type eye development | 8.905683e-4 |
GO:0070076 | histone lysine demethylation | 8.907904e-4 |
GO:0046464 | acylglycerol catabolic process | 8.952305e-4 |
GO:0050865 | regulation of cell activation | 8.999657e-4 |
GO:0035042 | fertilization, exchange of chromosomal proteins | 9.331225e-4 |
GO:0002674 | negative regulation of acute inflammatory response | 9.335205e-4 |
GO:0021860 | pyramidal neuron development | 9.395647e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 9.521173e-4 |
GO:0051289 | protein homotetramerization | 9.676414e-4 |
GO:0006954 | inflammatory response | 9.718171e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 9.184825e-13 |
GO:0016074 | snoRNA metabolic process | 3.751885e-10 |
GO:0005996 | monosaccharide metabolic process | 6.304145e-9 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 8.795946e-9 |
GO:0046164 | alcohol catabolic process | 5.318516e-8 |
GO:0019318 | hexose metabolic process | 8.795750e-8 |
GO:0009612 | response to mechanical stimulus | 1.417786e-7 |
GO:0060135 | maternal process involved in female pregnancy | 1.517727e-7 |
GO:0006006 | glucose metabolic process | 1.621271e-7 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 1.895002e-7 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 2.765767e-7 |
GO:0046365 | monosaccharide catabolic process | 2.875950e-7 |
GO:0060745 | mammary gland branching involved in pregnancy | 3.042487e-7 |
GO:0031129 | inductive cell-cell signaling | 3.200006e-7 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 3.324222e-7 |
GO:0043032 | positive regulation of macrophage activation | 6.443378e-7 |
GO:0048730 | epidermis morphogenesis | 6.634604e-7 |
GO:0060065 | uterus development | 9.879802e-7 |
GO:0090273 | regulation of somatostatin secretion | 1.019285e-6 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 1.179680e-6 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 1.252460e-6 |
GO:0071360 | cellular response to exogenous dsRNA | 1.252460e-6 |
GO:0015747 | urate transport | 1.330071e-6 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.380283e-6 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 1.725322e-6 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 1.914286e-6 |
GO:0019320 | hexose catabolic process | 1.988715e-6 |
GO:0032571 | response to vitamin K | 2.310751e-6 |
GO:0044275 | cellular carbohydrate catabolic process | 2.364519e-6 |
GO:0019255 | glucose 1-phosphate metabolic process | 2.649209e-6 |
GO:0051704 | multi-organism process | 2.738428e-6 |
GO:0043589 | skin morphogenesis | 2.802086e-6 |
GO:0010226 | response to lithium ion | 2.988449e-6 |
GO:0001969 | regulation of activation of membrane attack complex | 3.024964e-6 |
GO:0048584 | positive regulation of response to stimulus | 3.150316e-6 |
GO:0006098 | pentose-phosphate shunt | 4.191606e-6 |
GO:0048545 | response to steroid hormone stimulus | 4.566425e-6 |
GO:0044262 | cellular carbohydrate metabolic process | 4.791279e-6 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 4.932282e-6 |
GO:0031032 | actomyosin structure organization | 5.298894e-6 |
GO:0060231 | mesenchymal to epithelial transition | 5.379681e-6 |
GO:0001547 | antral ovarian follicle growth | 6.158139e-6 |
GO:0009967 | positive regulation of signal transduction | 6.377527e-6 |
GO:0045088 | regulation of innate immune response | 6.539667e-6 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 8.547645e-6 |
GO:2000380 | regulation of mesoderm development | 8.553151e-6 |
GO:0007166 | cell surface receptor linked signaling pathway | 8.694857e-6 |
GO:0060011 | Sertoli cell proliferation | 1.044218e-5 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 1.070067e-5 |
GO:0006739 | NADP metabolic process | 1.100245e-5 |
GO:0015851 | nucleobase transport | 1.140322e-5 |
GO:0072077 | renal vesicle morphogenesis | 1.160114e-5 |
GO:0001833 | inner cell mass cell proliferation | 1.160114e-5 |
GO:0006007 | glucose catabolic process | 1.318985e-5 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.348567e-5 |
GO:0045089 | positive regulation of innate immune response | 1.350505e-5 |
GO:0045766 | positive regulation of angiogenesis | 1.436225e-5 |
GO:0035356 | cellular triglyceride homeostasis | 1.472873e-5 |
GO:0030239 | myofibril assembly | 1.522150e-5 |
GO:0030520 | estrogen receptor signaling pathway | 1.539949e-5 |
GO:0007565 | female pregnancy | 1.615752e-5 |
GO:0007010 | cytoskeleton organization | 1.685928e-5 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.698252e-5 |
GO:2000381 | negative regulation of mesoderm development | 1.990447e-5 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 2.134964e-5 |
GO:0072033 | renal vesicle formation | 2.270751e-5 |
GO:0048583 | regulation of response to stimulus | 2.323401e-5 |
GO:0031936 | negative regulation of chromatin silencing | 2.383484e-5 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 2.564525e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 2.826375e-5 |
GO:0060837 | blood vessel endothelial cell differentiation | 2.856489e-5 |
GO:0010954 | positive regulation of protein processing | 2.982174e-5 |
GO:0050847 | progesterone receptor signaling pathway | 3.020052e-5 |
GO:0031341 | regulation of cell killing | 3.119368e-5 |
GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein | 3.222399e-5 |
GO:0030505 | inorganic diphosphate transport | 3.264560e-5 |
GO:2000384 | negative regulation of ectoderm development | 3.264560e-5 |
GO:0009116 | nucleoside metabolic process | 3.530089e-5 |
GO:0009225 | nucleotide-sugar metabolic process | 3.554025e-5 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 3.604905e-5 |
GO:0060969 | negative regulation of gene silencing | 3.726550e-5 |
GO:0006863 | purine base transport | 3.726550e-5 |
GO:0032814 | regulation of natural killer cell activation | 4.000917e-5 |
GO:0023056 | positive regulation of signaling | 4.109355e-5 |
GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein | 4.236814e-5 |
GO:0031935 | regulation of chromatin silencing | 4.294872e-5 |
GO:0010647 | positive regulation of cell communication | 4.319874e-5 |
GO:0060968 | regulation of gene silencing | 4.358131e-5 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 4.505419e-5 |
GO:0030518 | steroid hormone receptor signaling pathway | 4.681827e-5 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 4.746264e-5 |
GO:0045839 | negative regulation of mitosis | 4.826249e-5 |
GO:0043627 | response to estrogen stimulus | 4.827855e-5 |
GO:0016052 | carbohydrate catabolic process | 4.839789e-5 |
GO:0051127 | positive regulation of actin nucleation | 5.122317e-5 |
GO:0010035 | response to inorganic substance | 5.285412e-5 |
GO:0003338 | metanephros morphogenesis | 5.352314e-5 |
GO:0009119 | ribonucleoside metabolic process | 5.690262e-5 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 5.733740e-5 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 5.783256e-5 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 5.783256e-5 |
GO:0001656 | metanephros development | 5.900313e-5 |
GO:0048630 | skeletal muscle tissue growth | 5.995373e-5 |
GO:0044282 | small molecule catabolic process | 6.090219e-5 |
GO:2000383 | regulation of ectoderm development | 6.324472e-5 |
GO:0006936 | muscle contraction | 6.415273e-5 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 6.440384e-5 |
GO:0045919 | positive regulation of cytolysis | 6.730232e-5 |
GO:0031349 | positive regulation of defense response | 6.836773e-5 |
GO:0002699 | positive regulation of immune effector process | 7.045306e-5 |
GO:0080111 | DNA demethylation | 7.480438e-5 |
GO:0072087 | renal vesicle development | 7.994382e-5 |
GO:0030449 | regulation of complement activation | 8.728041e-5 |
GO:0051656 | establishment of organelle localization | 8.848547e-5 |
GO:0006882 | cellular zinc ion homeostasis | 9.174799e-5 |
GO:0060068 | vagina development | 9.246960e-5 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 9.400363e-5 |
GO:0072283 | metanephric renal vesicle morphogenesis | 9.815788e-5 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 9.838206e-5 |
GO:0060452 | positive regulation of cardiac muscle contraction | 1.006809e-4 |
GO:0072273 | metanephric nephron morphogenesis | 1.046750e-4 |
GO:0003012 | muscle system process | 1.064628e-4 |
GO:0048511 | rhythmic process | 1.103189e-4 |
GO:0002920 | regulation of humoral immune response | 1.109938e-4 |
GO:0043030 | regulation of macrophage activation | 1.111215e-4 |
GO:0051260 | protein homooligomerization | 1.133659e-4 |
GO:0001832 | blastocyst growth | 1.198089e-4 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1.236140e-4 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 1.270222e-4 |
GO:0060523 | prostate epithelial cord elongation | 1.348265e-4 |
GO:0071310 | cellular response to organic substance | 1.349534e-4 |
GO:0055069 | zinc ion homeostasis | 1.363421e-4 |
GO:0035234 | germ cell programmed cell death | 1.409287e-4 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 1.519978e-4 |
GO:0002287 | alpha-beta T cell activation involved in immune response | 1.525103e-4 |
GO:0030240 | skeletal muscle thin filament assembly | 1.525103e-4 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 1.567093e-4 |
GO:0048339 | paraxial mesoderm development | 1.579689e-4 |
GO:0031069 | hair follicle morphogenesis | 1.595645e-4 |
GO:0032700 | negative regulation of interleukin-17 production | 1.687539e-4 |
GO:0032496 | response to lipopolysaccharide | 1.687867e-4 |
GO:0030879 | mammary gland development | 1.818611e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 1.993055e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 2.011903e-4 |
GO:0072088 | nephron epithelium morphogenesis | 2.015620e-4 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 2.055352e-4 |
GO:0060427 | lung connective tissue development | 2.055352e-4 |
GO:0006000 | fructose metabolic process | 2.108702e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 2.210061e-4 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 2.221578e-4 |
GO:0009826 | unidimensional cell growth | 2.239723e-4 |
GO:0072092 | ureteric bud invasion | 2.239723e-4 |
GO:0055080 | cation homeostasis | 2.308947e-4 |
GO:0005975 | carbohydrate metabolic process | 2.362461e-4 |
GO:0006044 | N-acetylglucosamine metabolic process | 2.377006e-4 |
GO:0031343 | positive regulation of cell killing | 2.388548e-4 |
GO:0010623 | developmental programmed cell death | 2.409586e-4 |
GO:0031347 | regulation of defense response | 2.443886e-4 |
GO:0006925 | inflammatory cell apoptosis | 2.543854e-4 |
GO:0060658 | nipple morphogenesis | 2.543854e-4 |
GO:0002237 | response to molecule of bacterial origin | 2.544667e-4 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.585945e-4 |
GO:0097118 | neuroligin clustering | 2.589372e-4 |
GO:0030036 | actin cytoskeleton organization | 2.589495e-4 |
GO:0051707 | response to other organism | 2.657144e-4 |
GO:0010038 | response to metal ion | 2.681515e-4 |
GO:0070206 | protein trimerization | 2.725407e-4 |
GO:0007219 | Notch signaling pathway | 2.796942e-4 |
GO:0035510 | DNA dealkylation | 2.910523e-4 |
GO:0032648 | regulation of interferon-beta production | 2.941400e-4 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 2.965473e-4 |
GO:0051259 | protein oligomerization | 3.080464e-4 |
GO:0050801 | ion homeostasis | 3.095504e-4 |
GO:0046427 | positive regulation of JAK-STAT cascade | 3.168136e-4 |
GO:0006040 | amino sugar metabolic process | 3.309101e-4 |
GO:0009120 | deoxyribonucleoside metabolic process | 3.419041e-4 |
GO:0006955 | immune response | 3.476391e-4 |
GO:0019882 | antigen processing and presentation | 3.498858e-4 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 3.529686e-4 |
GO:0046415 | urate metabolic process | 3.572083e-4 |
GO:0051128 | regulation of cellular component organization | 3.769822e-4 |
GO:0042421 | norepinephrine biosynthetic process | 3.835261e-4 |
GO:0009628 | response to abiotic stimulus | 3.889047e-4 |
GO:0060749 | mammary gland alveolus development | 3.954770e-4 |
GO:0010260 | organ senescence | 3.965275e-4 |
GO:0015746 | citrate transport | 3.965275e-4 |
GO:0070278 | extracellular matrix constituent secretion | 3.965275e-4 |
GO:0010273 | detoxification of copper ion | 3.965275e-4 |
GO:0033865 | nucleoside bisphosphate metabolic process | 3.975801e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 4.059970e-4 |
GO:0002706 | regulation of lymphocyte mediated immunity | 4.152138e-4 |
GO:0043330 | response to exogenous dsRNA | 4.236661e-4 |
GO:0030261 | chromosome condensation | 4.348338e-4 |
GO:0010464 | regulation of mesenchymal cell proliferation | 4.382228e-4 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 4.418049e-4 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 4.545450e-4 |
GO:0009966 | regulation of signal transduction | 4.559719e-4 |
GO:0060443 | mammary gland morphogenesis | 4.616066e-4 |
GO:0072093 | metanephric renal vesicle formation | 4.657802e-4 |
GO:0030101 | natural killer cell activation | 4.685111e-4 |
GO:0002682 | regulation of immune system process | 4.690751e-4 |
GO:0090274 | positive regulation of somatostatin secretion | 4.787207e-4 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 4.824816e-4 |
GO:0009887 | organ morphogenesis | 4.903960e-4 |
GO:0071260 | cellular response to mechanical stimulus | 5.095246e-4 |
GO:0031214 | biomineral tissue development | 5.115894e-4 |
GO:0071899 | negative regulation of estrogen receptor binding | 5.182113e-4 |
GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 5.184422e-4 |
GO:0000003 | reproduction | 5.193682e-4 |
GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 5.219461e-4 |
GO:0007567 | parturition | 5.331877e-4 |
GO:0022414 | reproductive process | 5.415408e-4 |
GO:0051186 | cofactor metabolic process | 5.436863e-4 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 5.486589e-4 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 5.512333e-4 |
GO:0097116 | gephyrin clustering | 5.559213e-4 |
GO:0046939 | nucleotide phosphorylation | 5.592421e-4 |
GO:0042093 | T-helper cell differentiation | 5.592421e-4 |
GO:0070887 | cellular response to chemical stimulus | 5.772456e-4 |
GO:0030029 | actin filament-based process | 5.872028e-4 |
GO:0032355 | response to estradiol stimulus | 6.090933e-4 |
GO:0022604 | regulation of cell morphogenesis | 6.137189e-4 |
GO:0032964 | collagen biosynthetic process | 6.278944e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 6.329473e-4 |
GO:0046688 | response to copper ion | 6.394898e-4 |
GO:0007172 | signal complex assembly | 6.420109e-4 |
GO:0030838 | positive regulation of actin filament polymerization | 6.534382e-4 |
GO:0042306 | regulation of protein import into nucleus | 6.625075e-4 |
GO:0002064 | epithelial cell development | 6.742390e-4 |
GO:0051272 | positive regulation of cellular component movement | 6.891539e-4 |
GO:0032816 | positive regulation of natural killer cell activation | 6.903171e-4 |
GO:0009607 | response to biotic stimulus | 7.069937e-4 |
GO:2000147 | positive regulation of cell motility | 7.133860e-4 |
GO:0045765 | regulation of angiogenesis | 7.144461e-4 |
GO:0021889 | olfactory bulb interneuron differentiation | 7.234467e-4 |
GO:0006826 | iron ion transport | 7.293307e-4 |
GO:0043588 | skin development | 7.321161e-4 |
GO:0048754 | branching morphogenesis of a tube | 7.356824e-4 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 7.445197e-4 |
GO:0019428 | allantoin biosynthetic process | 7.519515e-4 |
GO:0001649 | osteoblast differentiation | 7.711024e-4 |
GO:0021553 | olfactory nerve development | 7.762971e-4 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 7.826918e-4 |
GO:0014866 | skeletal myofibril assembly | 7.866265e-4 |
GO:0072028 | nephron morphogenesis | 7.950635e-4 |
GO:0007566 | embryo implantation | 8.145924e-4 |
GO:0045214 | sarcomere organization | 8.206574e-4 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 8.276515e-4 |
GO:0001763 | morphogenesis of a branching structure | 8.349059e-4 |
GO:0002703 | regulation of leukocyte mediated immunity | 8.359742e-4 |
GO:0034059 | response to anoxia | 8.382036e-4 |
GO:0010627 | regulation of intracellular protein kinase cascade | 8.588888e-4 |
GO:0008544 | epidermis development | 8.670347e-4 |
GO:0035137 | hindlimb morphogenesis | 8.678497e-4 |
GO:0002318 | myeloid progenitor cell differentiation | 8.737919e-4 |
GO:0032119 | sequestering of zinc ion | 8.820312e-4 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 8.824387e-4 |
GO:0022603 | regulation of anatomical structure morphogenesis | 8.899060e-4 |
GO:0071495 | cellular response to endogenous stimulus | 8.902585e-4 |
GO:0009617 | response to bacterium | 8.964362e-4 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 9.444303e-4 |
GO:0080134 | regulation of response to stress | 9.558370e-4 |
GO:0070848 | response to growth factor stimulus | 9.669255e-4 |
GO:0051964 | negative regulation of synapse assembly | 9.700500e-4 |
GO:0006165 | nucleoside diphosphate phosphorylation | 9.700500e-4 |
GO:0006228 | UTP biosynthetic process | 9.700500e-4 |
GO:0006732 | coenzyme metabolic process | 9.781994e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 9.816949e-4 |
GO:0001826 | inner cell mass cell differentiation | 9.816949e-4 |
GO:0032667 | regulation of interleukin-23 production | 9.816949e-4 |
GO:0055062 | phosphate ion homeostasis | 1.005494e-3 |
GO:0030522 | intracellular receptor mediated signaling pathway | 1.011587e-3 |
GO:0034505 | tooth mineralization | 1.022050e-3 |
GO:0007004 | telomere maintenance via telomerase | 1.041173e-3 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.066682e-3 |
GO:0032479 | regulation of type I interferon production | 1.075533e-3 |
GO:0010810 | regulation of cell-substrate adhesion | 1.078315e-3 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 1.098864e-3 |
GO:0018214 | protein carboxylation | 1.107335e-3 |
GO:0018193 | peptidyl-amino acid modification | 1.120291e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 1.142438e-3 |
GO:0044281 | small molecule metabolic process | 1.144297e-3 |
GO:0051961 | negative regulation of nervous system development | 1.165715e-3 |
GO:0006183 | GTP biosynthetic process | 1.165715e-3 |
GO:0002697 | regulation of immune effector process | 1.173003e-3 |
GO:0051125 | regulation of actin nucleation | 1.226456e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 1.231059e-3 |
GO:0060157 | urinary bladder development | 1.232766e-3 |
GO:0031099 | regeneration | 1.240202e-3 |
GO:0060737 | prostate gland morphogenetic growth | 1.261989e-3 |
GO:0002367 | cytokine production involved in immune response | 1.274478e-3 |
GO:0002155 | regulation of thyroid hormone mediated signaling pathway | 1.276296e-3 |
GO:0001570 | vasculogenesis | 1.285073e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 1.289003e-3 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 1.302609e-3 |
GO:0001957 | intramembranous ossification | 1.313246e-3 |
GO:0060993 | kidney morphogenesis | 1.335087e-3 |
GO:0071363 | cellular response to growth factor stimulus | 1.335269e-3 |
GO:0042742 | defense response to bacterium | 1.336350e-3 |
GO:0071359 | cellular response to dsRNA | 1.342172e-3 |
GO:0042268 | regulation of cytolysis | 1.359281e-3 |
GO:0006996 | organelle organization | 1.364002e-3 |
GO:0002369 | T cell cytokine production | 1.365069e-3 |
GO:0042278 | purine nucleoside metabolic process | 1.414990e-3 |
GO:0031100 | organ regeneration | 1.458343e-3 |
GO:0060056 | mammary gland involution | 1.473692e-3 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.473692e-3 |
GO:0003382 | epithelial cell morphogenesis | 1.475891e-3 |
GO:0006241 | CTP biosynthetic process | 1.515703e-3 |
GO:0045925 | positive regulation of female receptivity | 1.546136e-3 |
GO:0042245 | RNA repair | 1.546136e-3 |
GO:0014719 | satellite cell activation | 1.546136e-3 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 1.546136e-3 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.552488e-3 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.553063e-3 |
GO:0002023 | reduction of food intake in response to dietary excess | 1.553063e-3 |
GO:0030335 | positive regulation of cell migration | 1.563134e-3 |
GO:0071956 | cellular component maintenance at cellular level | 1.575171e-3 |
GO:0042473 | outer ear morphogenesis | 1.575171e-3 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 1.674975e-3 |
GO:0045722 | positive regulation of gluconeogenesis | 1.677809e-3 |
GO:0060022 | hard palate development | 1.702185e-3 |
GO:0060066 | oviduct development | 1.768594e-3 |
GO:0002376 | immune system process | 1.773380e-3 |
GO:0042376 | phylloquinone catabolic process | 1.773756e-3 |
GO:0070613 | regulation of protein processing | 1.799777e-3 |
GO:0042982 | amyloid precursor protein metabolic process | 1.811292e-3 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.816041e-3 |
GO:0060676 | ureteric bud formation | 1.816041e-3 |
GO:0040017 | positive regulation of locomotion | 1.873235e-3 |
GO:0051222 | positive regulation of protein transport | 1.908672e-3 |
GO:0050715 | positive regulation of cytokine secretion | 1.919331e-3 |
GO:0032729 | positive regulation of interferon-gamma production | 1.919427e-3 |
GO:0002839 | positive regulation of immune response to tumor cell | 1.919573e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 1.960480e-3 |
GO:0002684 | positive regulation of immune system process | 1.981095e-3 |
GO:0040023 | establishment of nucleus localization | 2.009312e-3 |
GO:0006952 | defense response | 2.021421e-3 |
GO:0048070 | regulation of developmental pigmentation | 2.102455e-3 |
GO:0002837 | regulation of immune response to tumor cell | 2.102455e-3 |
GO:0014075 | response to amine stimulus | 2.109684e-3 |
GO:0010927 | cellular component assembly involved in morphogenesis | 2.168491e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 2.193117e-3 |
GO:0045759 | negative regulation of action potential | 2.200126e-3 |
GO:0070208 | protein heterotrimerization | 2.223553e-3 |
GO:0010043 | response to zinc ion | 2.226634e-3 |
GO:0046496 | nicotinamide nucleotide metabolic process | 2.260637e-3 |
GO:0051238 | sequestering of metal ion | 2.261544e-3 |
GO:0006066 | alcohol metabolic process | 2.309942e-3 |
GO:0070536 | protein K63-linked deubiquitination | 2.315067e-3 |
GO:0051291 | protein heterooligomerization | 2.437248e-3 |
GO:0045087 | innate immune response | 2.462304e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 2.463125e-3 |
GO:0030730 | sequestering of triglyceride | 2.542304e-3 |
GO:0050865 | regulation of cell activation | 2.551851e-3 |
GO:0001954 | positive regulation of cell-matrix adhesion | 2.557855e-3 |
GO:0031960 | response to corticosteroid stimulus | 2.568013e-3 |
GO:0002694 | regulation of leukocyte activation | 2.585374e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 2.589274e-3 |
GO:0060346 | bone trabecula formation | 2.622628e-3 |
GO:0002833 | positive regulation of response to biotic stimulus | 2.622628e-3 |
GO:0051726 | regulation of cell cycle | 2.634949e-3 |
GO:0043200 | response to amino acid stimulus | 2.637338e-3 |
GO:0060677 | ureteric bud elongation | 2.696564e-3 |
GO:0051289 | protein homotetramerization | 2.740818e-3 |
GO:0032273 | positive regulation of protein polymerization | 2.744421e-3 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 2.744593e-3 |
GO:0001824 | blastocyst development | 2.795932e-3 |
GO:0002286 | T cell activation involved in immune response | 2.833113e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 2.847491e-3 |
GO:0033598 | mammary gland epithelial cell proliferation | 2.928935e-3 |
GO:0050867 | positive regulation of cell activation | 2.968479e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 3.023122e-3 |
GO:0055002 | striated muscle cell development | 3.155071e-3 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 3.212666e-3 |
GO:0030155 | regulation of cell adhesion | 3.241048e-3 |
GO:0051894 | positive regulation of focal adhesion assembly | 3.298512e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 3.420665e-3 |
GO:0060541 | respiratory system development | 3.421039e-3 |
GO:0007015 | actin filament organization | 3.431240e-3 |
GO:0031659 | positive regulation of cyclin-dependent protein kinase activity involved in G1/S | 3.487970e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 3.489679e-3 |
GO:0034474 | U2 snRNA 3'-end processing | 3.489679e-3 |
GO:0031104 | dendrite regeneration | 3.489679e-3 |
GO:0016119 | carotene metabolic process | 3.489679e-3 |
GO:0030643 | cellular phosphate ion homeostasis | 3.496694e-3 |
GO:0046333 | octopamine metabolic process | 3.503165e-3 |
GO:0042309 | homoiothermy | 3.503165e-3 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 3.503165e-3 |
GO:0043526 | neuroprotection | 3.526768e-3 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 3.539611e-3 |
GO:0014045 | establishment of endothelial blood-brain barrier | 3.539611e-3 |
GO:0032649 | regulation of interferon-gamma production | 3.615963e-3 |
GO:0033157 | regulation of intracellular protein transport | 3.706411e-3 |
GO:0040020 | regulation of meiosis | 3.720011e-3 |
GO:0042633 | hair cycle | 3.769257e-3 |
GO:0071219 | cellular response to molecule of bacterial origin | 3.769823e-3 |
GO:0002540 | leukotriene production involved in inflammatory response | 3.793878e-3 |
GO:0060442 | branching involved in prostate gland morphogenesis | 3.823361e-3 |
GO:0051050 | positive regulation of transport | 3.854182e-3 |
GO:0031333 | negative regulation of protein complex assembly | 3.889922e-3 |
GO:0048286 | lung alveolus development | 3.928531e-3 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 3.929484e-3 |
GO:0043410 | positive regulation of MAPKKK cascade | 3.952036e-3 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 4.003611e-3 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 4.034407e-3 |
GO:0045815 | positive regulation of gene expression, epigenetic | 4.170270e-3 |
GO:0030003 | cellular cation homeostasis | 4.260893e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 4.280694e-3 |
GO:0048878 | chemical homeostasis | 4.291879e-3 |
GO:0044087 | regulation of cellular component biogenesis | 4.317263e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 4.336079e-3 |
GO:0090275 | negative regulation of somatostatin secretion | 4.377697e-3 |
GO:0006043 | glucosamine catabolic process | 4.377697e-3 |
GO:0045933 | positive regulation of muscle contraction | 4.393821e-3 |
GO:0012501 | programmed cell death | 4.435669e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 4.449188e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 4.563814e-3 |
GO:0070316 | regulation of G0 to G1 transition | 4.616437e-3 |
GO:0046121 | deoxyribonucleoside catabolic process | 4.616437e-3 |
GO:0035136 | forelimb morphogenesis | 4.624901e-3 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 4.640218e-3 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 4.694175e-3 |
GO:0006820 | anion transport | 4.933572e-3 |
GO:0001541 | ovarian follicle development | 4.981139e-3 |
GO:0030199 | collagen fibril organization | 5.168916e-3 |
GO:0001771 | immunological synapse formation | 5.204229e-3 |
GO:0060591 | chondroblast differentiation | 5.257477e-3 |
GO:0060281 | regulation of oocyte development | 5.257477e-3 |
GO:0060282 | positive regulation of oocyte development | 5.257477e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 5.278638e-3 |
GO:0051445 | regulation of meiotic cell cycle | 5.354980e-3 |
GO:0070094 | positive regulation of glucagon secretion | 5.372989e-3 |
GO:0006278 | RNA-dependent DNA replication | 5.422190e-3 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 5.433328e-3 |
GO:0046483 | heterocycle metabolic process | 5.446923e-3 |
GO:0071222 | cellular response to lipopolysaccharide | 5.477461e-3 |
GO:0048664 | neuron fate determination | 5.608080e-3 |
GO:0071391 | cellular response to estrogen stimulus | 5.614862e-3 |
GO:0031579 | membrane raft organization | 5.621492e-3 |
GO:0046128 | purine ribonucleoside metabolic process | 5.624221e-3 |
GO:0051495 | positive regulation of cytoskeleton organization | 5.721030e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 5.721513e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.721513e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 5.721513e-3 |
GO:0032707 | negative regulation of interleukin-23 production | 5.721513e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 5.721513e-3 |
GO:0019896 | axon transport of mitochondrion | 5.721513e-3 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 5.721513e-3 |
GO:0022610 | biological adhesion | 5.975763e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 5.980727e-3 |
GO:0031018 | endocrine pancreas development | 6.048318e-3 |
GO:0019693 | ribose phosphate metabolic process | 6.160015e-3 |
GO:0006873 | cellular ion homeostasis | 6.317548e-3 |
GO:0061138 | morphogenesis of a branching epithelium | 6.405750e-3 |
GO:0060405 | regulation of penile erection | 6.483690e-3 |
GO:0015937 | coenzyme A biosynthetic process | 6.483690e-3 |
GO:0021956 | central nervous system interneuron axonogenesis | 6.493269e-3 |
GO:0060525 | prostate glandular acinus development | 6.519305e-3 |
GO:0071418 | cellular response to amine stimulus | 6.566413e-3 |
GO:0001556 | oocyte maturation | 6.577792e-3 |
GO:0071230 | cellular response to amino acid stimulus | 6.691842e-3 |
GO:0038007 | netrin-activated signaling pathway | 6.694215e-3 |
GO:0002347 | response to tumor cell | 6.694215e-3 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 6.694215e-3 |
GO:0060675 | ureteric bud morphogenesis | 6.862357e-3 |
GO:0030002 | cellular anion homeostasis | 6.890835e-3 |
GO:0044085 | cellular component biogenesis | 6.891737e-3 |
GO:0007623 | circadian rhythm | 6.930924e-3 |
GO:0031577 | spindle checkpoint | 6.956832e-3 |
GO:0022009 | central nervous system vasculogenesis | 6.956832e-3 |
GO:0001503 | ossification | 6.970153e-3 |
GO:0019370 | leukotriene biosynthetic process | 7.073548e-3 |
GO:0051130 | positive regulation of cellular component organization | 7.170954e-3 |
GO:0006878 | cellular copper ion homeostasis | 7.204607e-3 |
GO:0000302 | response to reactive oxygen species | 7.237254e-3 |
GO:0055081 | anion homeostasis | 7.257191e-3 |
GO:0030323 | respiratory tube development | 7.317588e-3 |
GO:0042698 | ovulation cycle | 7.330808e-3 |
GO:0046590 | embryonic leg morphogenesis | 7.500367e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 7.504190e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 7.504190e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 7.590820e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 7.633831e-3 |
GO:0071422 | succinate transmembrane transport | 7.742223e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 7.742223e-3 |
GO:0060602 | branch elongation of an epithelium | 7.784479e-3 |
GO:0071417 | cellular response to organic nitrogen | 7.790765e-3 |
GO:0006766 | vitamin metabolic process | 7.793070e-3 |
GO:0001938 | positive regulation of endothelial cell proliferation | 7.944722e-3 |
GO:0002696 | positive regulation of leukocyte activation | 7.957565e-3 |
GO:0055082 | cellular chemical homeostasis | 7.972083e-3 |
GO:0009725 | response to hormone stimulus | 8.118583e-3 |
GO:0048861 | leukemia inhibitory factor signaling pathway | 8.150916e-3 |
GO:0022607 | cellular component assembly | 8.154967e-3 |
GO:0050896 | response to stimulus | 8.202682e-3 |
GO:0010243 | response to organic nitrogen | 8.302703e-3 |
GO:0051160 | L-xylitol catabolic process | 8.442942e-3 |
GO:0071284 | cellular response to lead ion | 8.442942e-3 |
GO:0046370 | fructose biosynthetic process | 8.442942e-3 |